DE3306622A1 - Bio-verfuegbare eisenderivate, die keine gastrischen schaeden verursachen, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel - Google Patents

Bio-verfuegbare eisenderivate, die keine gastrischen schaeden verursachen, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel

Info

Publication number
DE3306622A1
DE3306622A1 DE19833306622 DE3306622A DE3306622A1 DE 3306622 A1 DE3306622 A1 DE 3306622A1 DE 19833306622 DE19833306622 DE 19833306622 DE 3306622 A DE3306622 A DE 3306622A DE 3306622 A1 DE3306622 A1 DE 3306622A1
Authority
DE
Germany
Prior art keywords
iron
succinylated
protein
derivatives
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19833306622
Other languages
German (de)
English (en)
Other versions
DE3306622C2 (enExample
Inventor
Pietro Milano Cremonesi
Pier Giuseppe Pagella
Giancarlo Sportoletti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Italfarmaco SpA
Original Assignee
Italfarmaco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco SpA filed Critical Italfarmaco SpA
Publication of DE3306622A1 publication Critical patent/DE3306622A1/de
Application granted granted Critical
Publication of DE3306622C2 publication Critical patent/DE3306622C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/77—Ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/832—Milk; colostrum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/843—Digestive system
    • Y10S530/846—Liver

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE19833306622 1982-03-02 1983-02-25 Bio-verfuegbare eisenderivate, die keine gastrischen schaeden verursachen, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel Granted DE3306622A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19908/82A IT1150213B (it) 1982-03-02 1982-03-02 Derivati di ferro biodisponibile esenti da gastrolesivita',procentimento di preparazione e relative composizioni farmaceutiche

Publications (2)

Publication Number Publication Date
DE3306622A1 true DE3306622A1 (de) 1983-09-15
DE3306622C2 DE3306622C2 (enExample) 1990-02-22

Family

ID=11162241

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19833306622 Granted DE3306622A1 (de) 1982-03-02 1983-02-25 Bio-verfuegbare eisenderivate, die keine gastrischen schaeden verursachen, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel

Country Status (30)

Country Link
US (1) US4493829A (enExample)
JP (1) JPS58159421A (enExample)
KR (1) KR860001571B1 (enExample)
AR (1) AR229805A1 (enExample)
AT (1) AT390067B (enExample)
AU (1) AU548034B2 (enExample)
BE (1) BE896051A (enExample)
BR (1) BR8301005A (enExample)
CA (1) CA1222508A (enExample)
CH (1) CH653893A5 (enExample)
DE (1) DE3306622A1 (enExample)
DK (1) DK159824C (enExample)
ES (1) ES8403493A1 (enExample)
FI (1) FI77574C (enExample)
FR (1) FR2522664B1 (enExample)
GB (1) GB2115821B (enExample)
GR (1) GR78470B (enExample)
HK (1) HK56086A (enExample)
IE (1) IE54572B1 (enExample)
IN (1) IN156079B (enExample)
IT (1) IT1150213B (enExample)
LU (1) LU84672A1 (enExample)
MX (1) MX9203631A (enExample)
MY (1) MY8600588A (enExample)
NL (1) NL190399C (enExample)
NO (1) NO163859C (enExample)
PH (1) PH18538A (enExample)
PT (1) PT76318B (enExample)
SE (1) SE462716B (enExample)
ZA (1) ZA831350B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1186787B (it) * 1985-11-06 1987-12-16 Mediolanum Farmaceutici Srl Ferro-derivati della globina e dell'acetilglobina dotati di elevata biodisponibilita',processo di preparazione e composizioni farmaceutiche
IT1207996B (it) * 1986-03-18 1989-06-01 Magis Farmaceutici Composti contenenti ferro biodisponibile, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
JP2520262B2 (ja) * 1987-08-21 1996-07-31 春幸 川原 パツチテスト材料
IT1222912B (it) * 1987-10-14 1990-09-12 Italfarmaco Spa Derivati polipeptidici a elevato tenore di ferro e altamente solubili atti alla terapia marziale procedimenti di preparazione e loro forme farmaceutiche
IT1223122B (it) * 1987-11-13 1990-09-12 Unibios Spa Derivati proteici del ferro altamente biodisponibile e tollerabili, loro preparazione e composizioni farmaceutiche che li contengono
US5322678A (en) * 1988-02-17 1994-06-21 Neorx Corporation Alteration of pharmacokinetics of proteins by charge modification
IT1237783B (it) * 1989-11-16 1993-06-17 Italfarmaco Spa Derivati di ferro-albumina biodisponibile, loro procedimento di preparazione e relative composizioni farmaceutiche.
IT1251702B (it) * 1991-10-16 1995-05-19 Mediolanum Farmaceutici Srl Complessi del ferro con la conalbumina e i suoi derivati
IT1251725B (it) * 1991-11-04 1995-05-23 Italfarmaco Spa Composti di ferro biodisponibile con ovotransferrina acilata o suoi derivati di idrolisi acilati
IT1291289B1 (it) * 1997-04-30 1999-01-07 Derivati Organici Lab Complessi costituiti da fe(iii) un composto poliidrossilato e ovalbumina
ITMO20040200A1 (it) * 2004-07-29 2004-10-29 Biofer Spa Processo per la produzione di complessi ferro succinilcaseina e ferro casein acetil aspartilato e loro utilizzato nelle relative composizioni farmaceutiche.
JP2009518350A (ja) * 2005-12-06 2009-05-07 ヴィフォー・インターナショナル・アーゲー フェリ−スクシニルカゼインの製造方法
CA2726700C (en) * 2008-06-12 2018-05-22 Universite Laval Modified protein excipient for delayed-release tablet
PL2588488T3 (pl) 2010-06-30 2017-09-29 Italfarmaco Spa Kompleks sukcynylokazeiny z żelazem (III) i sposób jego wytwarzania
CN102838667B (zh) * 2012-09-25 2014-06-25 济川药业集团有限公司 一种蛋白琥珀酸铁的制备方法
BR112016015766A2 (pt) 2014-01-06 2017-08-08 Iron Therapeutics Holdings Ag Regime de dosagem de trimaltol férrico
GB201416293D0 (en) 2014-09-15 2014-10-29 Solvotrin Therapeutics Ltd Methods and preparations
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen
NO3034512T3 (enExample) 2014-12-19 2018-05-05
PL3429560T3 (pl) 2016-03-15 2025-04-28 Solvotrin Therapeutics Ltd. Kompozycje i sposoby zwiększania przyjmowania żelaza u ssaka

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3712865A (en) * 1968-12-31 1973-01-23 Lever Brothers Ltd Edible oil emulsions
US3764711A (en) * 1971-03-29 1973-10-09 Carnation Co Acylated protein for coffee whitener formulations
DE2539778A1 (de) * 1974-09-20 1976-04-08 Diagnostic Data Inc N-acetyliertes orgotein
GB1575577A (en) * 1976-12-17 1980-09-24 Ashmead H Compositions containing metal chelates

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2932589A (en) * 1956-03-12 1960-04-12 Glidden Co Paper coating compositions and process
IL26551A (en) * 1965-10-08 1970-06-17 Diagnostic Data Inc Injectable protein and method of isolation and use
US3756682A (en) * 1967-02-13 1973-09-04 Schlumberger Technology Corp Method for outgassing permanent magnets
US3873296A (en) * 1968-06-24 1975-03-25 Ashmead H H Increasing metals in biological tissue
US4020158A (en) * 1975-08-08 1977-04-26 Ashmead H H Increasing metals in biological tissue
US4208405A (en) * 1977-01-24 1980-06-17 Kelatron Pharmaceutical Division of Intermountain Laboratories Inc. Trace element composition for iron deficiency anemia
US4172072A (en) * 1977-10-20 1979-10-23 Ashmead H H Buffered enzymatically produced metal proteinates
US4216144A (en) * 1977-10-20 1980-08-05 Ashmead H H Soluble iron proteinates
SE451539B (sv) * 1979-11-16 1987-10-19 Sik Svenska Livsmedelsinst Hemjernanrikat aminosyrapreparat framstellt av hemproteiner och forfarande for dess framstellning

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3712865A (en) * 1968-12-31 1973-01-23 Lever Brothers Ltd Edible oil emulsions
US3764711A (en) * 1971-03-29 1973-10-09 Carnation Co Acylated protein for coffee whitener formulations
DE2539778A1 (de) * 1974-09-20 1976-04-08 Diagnostic Data Inc N-acetyliertes orgotein
GB1575577A (en) * 1976-12-17 1980-09-24 Ashmead H Compositions containing metal chelates

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DE-OS 21 01 866, Seite 1 *

Also Published As

Publication number Publication date
IE830428L (en) 1983-09-02
FR2522664A1 (fr) 1983-09-09
FI77574B (fi) 1988-12-30
MX9203631A (es) 1992-07-01
SE8301129L (sv) 1983-09-03
AU548034B2 (en) 1985-11-21
DE3306622C2 (enExample) 1990-02-22
KR840003648A (ko) 1984-09-15
GR78470B (enExample) 1984-09-27
JPH0470317B2 (enExample) 1992-11-10
FR2522664B1 (fr) 1986-08-14
NO830707L (no) 1983-09-05
IT8219908A0 (it) 1982-03-02
GB2115821A (en) 1983-09-14
DK84883A (da) 1983-09-03
FI77574C (fi) 1989-04-10
ES519944A0 (es) 1984-04-01
HK56086A (en) 1986-08-01
BE896051A (nl) 1983-07-01
DK159824B (da) 1990-12-10
DK159824C (da) 1991-04-29
IE54572B1 (en) 1989-11-22
JPS58159421A (ja) 1983-09-21
SE8301129D0 (sv) 1983-03-01
CH653893A5 (it) 1986-01-31
LU84672A1 (fr) 1983-09-08
NL8300757A (nl) 1983-10-03
KR860001571B1 (ko) 1986-10-08
NL190399C (nl) 1994-02-16
FI830678L (fi) 1983-09-03
GB8305691D0 (en) 1983-04-07
BR8301005A (pt) 1983-11-22
GB2115821B (en) 1985-07-17
CA1222508A (en) 1987-06-02
AR229805A1 (es) 1983-11-30
MY8600588A (en) 1986-12-31
NO163859C (no) 1990-08-01
AT390067B (de) 1990-03-12
AU1185883A (en) 1983-09-08
ZA831350B (en) 1983-11-30
US4493829A (en) 1985-01-15
PH18538A (en) 1985-08-09
IT1150213B (it) 1986-12-10
PT76318A (en) 1983-04-01
NL190399B (nl) 1993-09-16
IN156079B (enExample) 1985-05-11
DK84883D0 (da) 1983-02-24
ES8403493A1 (es) 1984-04-01
SE462716B (sv) 1990-08-20
PT76318B (en) 1986-02-12
NO163859B (no) 1990-04-23
ATA70983A (de) 1989-08-15
FI830678A0 (fi) 1983-03-01

Similar Documents

Publication Publication Date Title
DE3306622C2 (enExample)
CH638819A5 (de) Inklusionskomplex des cyclodextrins mit indomethacin und verfahren zur herstellung des komplexes.
DE2714128A1 (de) Essentielle metallionenkomplexe von oligo- beziehungsweise polygalakturonsaeuren, solche enthaltende arzneimittel und nahrungsmittel sowie verfahren zur herstellung derselben
DE2240782A1 (de) Verfahren zur herstellung eines eisensaccharid-komplexes
DE69106656T2 (de) Tanninextrakt von Kastanienholz, Verfahren zu deren Herstellung und deren Verwendung.
CH637913A5 (de) Biologisch wirksame eisen(ii)-verbindung, eisenpraeparat und verfahren zur herstellung der eisen(ii)-verbindung.
DE3206911A1 (de) Biochemischer wirkstoff, dessen herstellung und diesen wirkstoff enthaltendes mittel
EP0894094B1 (de) Verfahren zur gewinnung eines komplexes aus wachstumsfaktoren
DE2433209A1 (de) Hitzestabile plasmaproteinloesungen, verfahren zu ihrer herstellung und arzneipraeparate
DE602004000665T2 (de) Biologisches Verfahren zur Herstellung eines Hämeisenpräparats und daraus hergestellte Nahrungsmittelprodukte
DE3019032C2 (de) Antacider Wirkstoff auf Magnesium-Aluminiumhydroxid-Basis, seine Herstellung und Verwendung
EP0308362A1 (de) Eisen-Citrat-Komplex, Verfahren für seine Herstellung und seine pharmazeutische Verwendung
DE69212947T2 (de) Conalbumin und seine Derivate enthaltende Eisenkomplexe
DE10149668A1 (de) Insulinmimetische Aminosäuresequenzen
DE2510663B2 (de) Aluminiumpolyhydroxisulfat sowie dieses enthaltendes Arzneimittel
DE3844065A1 (de) Glycosidische eisen-ii- und eisen-iii-komplexzubereitungen und ihre verwendung
DE1768655B2 (enExample)
EP0061508A1 (de) Verfahren zur Gewinnung von Bienenkittharz enthaltenden Produkten und Bienenkittharz enthaltende Produkte
DE69100053T2 (de) Arzneimittelzusammensetzung in stabiler wässriger Suspensionsform auf der Basis von Sucralfat und einem Antacidum sowie Verfahren zu ihrer Herstellung.
DE3225597A1 (de) Verfahren zur herstellung eines gewebepraeparates
DE1936723C2 (de) Salze von Chinarindenalkoloiden und Verfahren zu ihrer Herstellung
DE2901914C2 (de) Zinksalz der 6-N-Acetylamino-capronsäure, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
DE2759032C2 (enExample)
DE3410850A1 (de) Arzneimittel zum verstaerken von blutgefaessen und dessen verwendung
DE69902866T2 (de) Extrakte aus kuhausscheidungen mit antikrebs- und antiinflammatorischer wirksamkeit sowie verfahren zu deren herstellung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee